Application
18382979 · RECOMBINANT PROTEIN VACCINES FORMULATED WITH ENANTIO-SPECIFIC CATIONIC LIPID R-DOTAP AND METHODS OF USE THEREOF
Filed 2023-10-23 · Pending The official file ↗ · Art unit 1671 · Examiner Benjamin P Blumel Typical · CPC A61K 39/12 · PDS BIOTECHNOLOGY CORPORATION · c/o DLA Piper LLP (US)
Office actions
1
first was Restriction requirement
RCEs
0
no appeal
To first action
28.3 mo
to disposition n/a
Statutes raised
102 103 DP
1 actions read